The First 30 Million-Contract Quarter Sets Records Across the Board, but a Flat Tape and a Full Multiple Argue for Patience

Results vs. Consensus

Year-over-Year Comparison

Sequential (QoQ) Comparison

Revenue — volume did the work

Total revenue of $1.69B (+10.4% YoY) was almost entirely a clearing-and-transaction-fee story: the fee line of $1.39B (+11%) was the highest in CME's history and contributed roughly 82% of revenue. Market data continued its quiet compounding at a record $198M (+13%), a reminder that the data franchise is a high-margin annuity that grows with the value of the underlying markets. The gap between +16% volume growth and +11% fee growth is the RPC drag, and it is the single most important nuance in the print: CME is monetizing a rising share of lower-fee retail and financial contracts. Management is explicit that it manages revenue, not RPC, and on the evidence of the quarter that is the right call, but it does mean the volume headline overstates the fee-revenue trajectory.

Margins — leverage on a fixed-cost base

The 71% adjusted operating margin (up ~190bp YoY) is the clearest demonstration of why this business is prized: the cost base is largely fixed, so incremental volume drops through at very high marginal margins. Adjusted expenses of $491M (or $395M ex-license fees) grew far slower than revenue, and management actually reduced the full-year expense guide. On a GAAP basis the operating margin was 66.7% ($1,129.3M on $1,692.0M). At this level of profitability the marginal question is not whether CME is a great business, it plainly is, but how much of that quality is already capitalized in the multiple.

EPS — record, and cleanly earned

Adjusted diluted EPS of $2.96 (+15.6% YoY) beat the ~$2.93 consensus and was the highest in company history, as was the $2.81 GAAP figure (+16.1%). The earnings growth outran revenue growth (10.4%) because of the operating leverage plus a stable ~360M share count, a variable dividend that returns cash rather than aggressively shrinking the count, and a modest non-operating contribution. This is high-quality EPS: it is operationally sourced, not manufactured by buybacks or a tax windfall. The caveat is forward-looking rather than about the quarter itself: a chunk of non-operating income comes from earning a spread on the ~$133B of average cash collateral CME holds, and that line is rate-sensitive as the Fed moves toward cuts.

Segment Performance

CME does not report profit by product line, but it discloses ADV and rate per contract for each of its six asset classes, and those two variables drive the fee engine. The quarter's defining feature is breadth: every asset class grew year-over-year, and the two largest (interest rates and equity indexes) were joined by a standout quarter in energy and metals.

Average Daily Volume by Product Line

Rate Per Contract by Product Line

Interest Rates — the engine, at an all-time volume record

Interest rate futures and options averaged 15.5M contracts per day, up 20% year-over-year and a new all-time quarterly record, and remain the largest single driver of the fee engine. The backdrop is exactly what CME wants: record levels of sovereign debt issuance in the US and, increasingly, Europe; persistent uncertainty about the Fed's path; and a Treasury complex where BrokerTec's cash platform sits alongside the futures book. The RPC held at $0.481, essentially flat, which matters because rates is the lowest-RPC book, so its outsized volume growth is a mild drag on the blended average even as it is a clear positive for dollars of fee revenue.

Assessment: This is the pillar of the franchise and it is compounding. The debt-issuance and rate-volatility tailwinds are structural rather than cyclical, and SOFR's entrenchment as the benchmark makes CME's rates complex extraordinarily hard to dislodge. The one thing to watch is the emergence of FMX (the Lutnick-backed rates challenger), which we treat as a low-probability but non-trivial competitive tail.

Equity Indexes — retail-fueled, seasonally softer sequentially

Equity index ADV of 7.7M grew 13% year-over-year but slipped 4.2% sequentially off a very strong Q1, consistent with a calmer volatility regime as the quarter progressed. The more important sub-plot is the retail Micro suite: Micro E-mini NASDAQ 100 contributed 1.7M of the 4.1M total Micros ADV, and year-to-date NASDAQ 100 futures and options volume is running above 2.5M contracts per day (+22%). Management's 10-year renewal of the exclusive NASDAQ index license through 2039, at unchanged economics, secures the franchise that underpins this growth.

Assessment: Equities is where CME's retail strategy is most visible and most additive. The Micros carry lower RPC but they broaden the base and are extraordinarily sticky once a retail cohort establishes a habit. The license extension removes a multi-year overhang. Net positive, though the sequential softness is a reminder that equity volumes track volatility, which no one can forecast.

Energy — the standout, on supply-chain realignment

Energy ADV of 3.1M jumped 26% year-over-year, the fastest growth of any asset class, as tariff-driven and geopolitical realignment of global physical supply chains (US now exporting record volumes of energy) pushed hedging activity to records. The commodities leadership framed it as basis risk: the differential between CME's futures and cash markets widens when trade flows dislocate, and that basis has to be managed, showing up as record exchange-for-physical and options activity. RPC did erode to $1.138 on product mix, but energy is a high-RPC book so its volume growth is disproportionately accretive to fee dollars.

Assessment: Energy is doing exactly what a diversified commodity exchange should do in a fractured trade environment: monetizing volatility and basis dislocation. Some of this is cyclical (tariff-driven), but the structural story (US as a swing energy exporter needing benchmark risk-transfer) has legs. A genuine bright spot in the quarter.

Metals — record retail gold, strong sequential snap-back

Metals ADV of 943k rose 9% year-over-year and 29% sequentially, aided by the gold rally toward $3,500/oz that pulled in both institutional hedgers and a wave of retail Micro gold traders. RPC softened to $1.456 as the Micro mix grew. Together with agriculturals (record volume, RPC rising to $1.435), the commodity complex delivered record first-half revenue.

Assessment: Metals is small in the mix but demonstrates the flywheel: a headline-grabbing move in the underlying (gold) pulls retail into the Micro product, which then cross-sells into the broader complex. The commodity franchise as a whole (energy, ags, metals) is proving it can grow independently of the financial books, which is exactly the diversification the bull case rests on.

Foreign Exchange — smallest book, new-platform optionality

FX ADV of 1.1M grew a modest 2% year-over-year and dipped sequentially, the quietest of the six books. The forward-looking item is FX Spot+, launched in April, which combines CME's spot and futures FX liquidity: management cited a $2.7B single-day volume and nearly 50 active entities, including a few dozen banks new to CME's FX futures.

Assessment: FX is not a needle-mover today, but FX Spot+ is a credible attempt to widen the funnel by attracting spot-first bank participants into the futures pool. Early and small, but the strategic logic (combine liquidity pools to win new participants) is sound. We assign it option value, not base-case revenue.

Key KPIs

Key Topics & Management Commentary

Overall Management Tone: Management was confident and expansive, leaning on the record-breaking numbers rather than promotion, and the call had an unusual amount of segment-head participation, with the CEO deferring to the commercial, commodities, fixed-income, and clearing leads on their books. The posture was assured but disciplined on the two areas where discipline matters: the CEO refused to forecast volumes ("it's really hard to predict") and declined entirely to speculate on the ongoing floor-trader litigation. The one place the tone was slightly softer than the numbers was on rate per contract, where the CFO reframed the metric away from investors rather than defend it.

1. The First 30 Million-Contract Quarter

"For the first time in CME Group's history, average daily volume exceeded 30 million contracts for this quarter. Second quarter average daily volume of 30.2 million contracts represented an increase of 16% compared to the same period last year and included all-time records in each month of the quarter." — Terry Duffy, Chairman & CEO

The headline milestone is not just the round number but its composition: growth in all six asset classes, all-time quarterly records in interest rates, agriculturals and metals, financial-product volume up 17% and commodity-sector volume up 15%. Breadth like this is the difference between a volatility spike (one or two books surging) and a structural step-up in the demand for risk transfer. Open interest, the stock of positions on the book, was up 7% versus a year ago and 10% versus year-end, which is the more durable signal because it reflects positions held rather than churned.

Assessment: A genuinely impressive quarter and the strongest possible confirmation of the secular thesis that a more volatile, more indebted, more geopolitically fractured world needs more hedging. The caution is simply that Q2 sets a very high bar: the year-over-year comps in H2 and into 2026 get materially harder, and a reversion to a calmer regime is always possible.

2. Rate Per Contract: Managed Away, Not Up

"We are not focused on growing RPC. We're focused on growing that revenue base and growing the opportunities that our clients have to trade. So I would focus more on that overall revenue picture than the RPC growth per se." — Lynne Fitzpatrick, CFO

The blended RPC of $0.690 was down 2.5% year-over-year, and the CFO's answer to a direct question on the RPC outlook was to redirect analysts away from the metric. Her framing identified two offsetting forces: international growth (non-member activity at higher RPC) is a tailwind, while retail Micros (smaller contracts at lower RPC) are a headwind, and the net has been modestly negative. The logic is defensible: a lower-RPC contract that would not otherwise exist is pure incremental revenue, so RPC dilution driven by genuine new volume is a good problem.

Assessment: We agree with the strategy but note the modeling consequence. Because fee revenue grows with volume × RPC, persistent RPC erosion means investors should haircut the read-through from headline volume records to fee dollars. The bull case cannot lean on 16% volume growth translating one-for-one into fee growth; the last two quarters show the conversion is closer to 11%.

3. Retail: 90,000 New Traders and a Fifth Straight Record

"This is now our fifth consecutive quarter of double-digit retail client acquisition growth… total participation across our marketplace for retail saw a significant 16% increase this quarter as well." — Julie Winkler, Chief Commercial Officer

Over 90,000 new retail traders entered CME's markets in the quarter, up 56% year-over-year, contributing to a record 4.1M Micros ADV. The commercial lead detailed a three-pillar strategy (partnering with new-to-futures brokers, expanding product access, and trader education), and disclosed that retail is diversifying well beyond Micro equities: Micro gold up 37%, Micro Bitcoin up 94%, Micro Ether up 212%, with retail RPC up 7% sequentially to $0.349. The CEO's own framing was notably patient: he wants these traders educated and retained rather than trading at maximum size on day one.

Assessment: This is the most credible of CME's growth vectors and the one most likely to be underappreciated by the market. Retail cohorts, once acquired and educated, are sticky and cross-sell across asset classes, and the RPC on retail is rising even as it dilutes the blended average. The risk is that retail engagement is itself somewhat pro-cyclical with market excitement (crypto, gold), so a dull market would slow acquisition.

4. International: Record 9.2M ADV, APAC Leading

International ADV reached a record 9.2M contracts per day (+18%), led by EMEA at 6.7M (+15%) and APAC at 2.2M (+30%). Growth was broad by asset class (international equity indices +38%, energy +23%, rates +14%, metals +14%) and concentrated in the Tier 1 sales-focus countries (France, UK, Switzerland, UAE, Netherlands in EMEA; Singapore, India, China in APAC). The commercial lead tied it to commercial hedgers diversifying benchmarks, sell-side demand for global liquidity, and buy-side demand for capital efficiency after the tariff shock.

Assessment: International is a structural share-gain story: non-US participants are still under-penetrated in CME's benchmark products, and the higher non-member RPC makes this growth accretive to the blended rate. APAC's +30% is the standout. This is a multi-year runway and a genuine offset to the maturity of the US institutional base.

5. Collateral Float and Investment Income — the rate-sensitive kicker

"Our total collateral posted this quarter averaged $316 billion… Of that, about $133 billion was in cash, and $145 billion was in noncash collateral. So of the required amount, you had almost 48% posted in cash. I would note that the floor or the soft minimum was placed at 30%." — Lynne Fitzpatrick, CFO

A new soft minimum requiring at least 30% of performance-bond collateral in cash took effect April 1, coinciding with the April volatility spike, and drove cash collateral to ~48% of the required amount (~$133B average). CME earns a spread on that cash, which flows through the non-operating lines: gross investment income of $1,518M is largely passed back to clearing members ($1,372M in "other non-operating expense"), leaving a net float-and-investment contribution of roughly $146M in the quarter. Management expects cash balances to "rightsize" toward the 30% floor as clients acclimate and volatility normalizes.

Assessment: This is the most important forward risk in the model and it is easy to miss because it sits below the operating line. The net collateral spread is meaningfully rate-sensitive: as the Fed cuts, both the yield on cash and, at the margin, the willingness to hold cash over the 30% floor can fall. We size this as a low-nine-figure annual headwind under a normalizing-rate scenario, partly offsetting operating-line growth into 2026. It does not change the quality of the franchise, but it does temper the earnings trajectory.

6. Crypto: Fast Follower With Real Momentum

"We're through end of last week doing almost 260,000 contracts per day in our crypto complex, which is over $12 billion of notional… with our new record large open interest holder in the complex of almost 800 large traders." — Tim McCourt, Global Head of Equity & FX Products

Crypto averaged roughly 190,000 contracts per day in the quarter (up ~130% year-over-year) and accelerated into July toward 260,000. The CEO positioned CME candidly as a "fast follower" rather than a first mover, arguing that its edge is the regulated venue and the reference prices that mainstream financial participants trust. On perpetual futures, the recurring product buzzword, he was careful: perpetuals are not currently legal in the US, and are ill-suited to physically deliverable products even if permitted, so any move would be confined to cash-settled crypto.

Assessment: Crypto is a credible incremental growth vector with genuine momentum, and CME's regulated-venue positioning is defensible. But it is still a small fraction of volume, and the competitive field (crypto-native venues, potential perpetuals) is fluid. We treat it as upside optionality rather than a core pillar, and note the CEO's discipline in not overpromising.

7. BrokerTec and the Cash-Treasury Franchise

"BrokerTec had an exceptional Q2. Our average daily notional volume of $949 billion was up 24%… on April 7, BrokerTec had one of its highest volume days, reaching $322 billion in U.S. Treasury actives traded on our platform." — Mike Dennis, Head of Fixed Income

Fixed-income cash trading via BrokerTec posted $949B average daily notional (+24%), with a record repo quarter ($362.9B) and a second consecutive record in RV curve. The fixed-income lead pushed back on the narrative that CME's Treasury share had slipped, arguing that like-for-like (central-limit-order-book, on-the-run actives) share is flat, and highlighted the September 15 launch of BrokerTec Chicago, a second matching engine co-located with the futures complex in the Aurora data center, as a client-acquisition catalyst.

Assessment: BrokerTec is the connective tissue between CME's cash and futures Treasury franchises, and the co-location move is strategically sound (tighter tick increments, latency parity with competitors, cross-margining potential with futures). The share-loss concern is worth monitoring but the management rebuttal is credible. Net neutral-to-positive.

8. Expense Discipline: Guide Trimmed $15M

"We now expect total adjusted operating expenses for the year, excluding license fees, to be approximately $1.635 billion. That is $15 million below our prior guidance and represents 3% growth from last year's adjusted expense levels." — Lynne Fitzpatrick, CFO

In a quarter of record revenue, management lowered rather than raised the expense guide, citing two drivers: optimization of the Google Cloud migration spend (finding ways to minimize incremental cost as more applications move) and lighter professional-services/consulting usage across the firm. Holding expense growth to 3% against double-digit revenue growth is the mechanical source of the margin expansion.

Assessment: This is exactly the discipline that justifies the quality multiple: management is not spending the volume windfall. The Google Cloud migration, which has been an expense-overhang worry, is now being framed as a source of savings rather than surprise cost. Clearly positive for near-term margins; the only caveat is that a multi-year cloud migration can still deliver lumpy quarters.

9. Tokenization and Stablecoins: A 2026 Story

"We are very optimistic about our ability to bring to market a solution in 2026… the movement of value on a 24/7 basis can really bring increased efficiencies into our ecosystem." — Suzanne Sprague, Chief Operating Officer & Global Head of Clearing

Management detailed its Google Cloud Universal Ledger partnership, now in a second phase of testing with settlement banks, aimed at tokenizing cash and non-cash assets for 24/7 movement of value, with a targeted market solution in 2026. The CEO underlined that the strategic point is efficiency (capital and operational) rather than chasing a headline, and was deliberately cautious on 24/7 trading more broadly, noting the staffing cost to member firms and the asset-class-by-asset-class regulatory hurdles.

Assessment: The right posture: engage with tokenization as an efficiency tool built on an existing Google partnership, rather than as a speculative land-grab. A 2026 solution is far enough out that it carries no near-term earnings weight, but it does inoculate CME against the "disrupted by tokenization" bear narrative by putting the company on the front foot. Optionality, not a near-term catalyst.

10. Capital Return and M&A Discipline

"We still have our variable dividend structure and the ability to return cash through that valve, and we have the addition of the share repurchase that we can look to utilize if we see some disconnects in terms of trading versus performance." — Lynne Fitzpatrick, CFO

CME paid $455M of dividends in the quarter and ~$3.0B over the first half, and has returned $29.1B via dividends since adopting the variable-dividend policy in 2012. The newer opportunistic buyback is positioned as a tool for when the stock disconnects from performance, not a standing program. On M&A, the CFO signaled continued but selective interest, favoring joint ventures and commercial agreements (like the NASDAQ extension) over large international acquisitions.

Assessment: CME's capital-return model is a core part of the total-return case: a capital-light business that converts almost all earnings to cash and returns most of it. The discipline on M&A is reassuring given the value-destruction history of large exchange mergers. This underpins the Hold rather than a lower rating; you are paid to wait via the dividend.

Guidance & Outlook

CME gives limited formal guidance, deliberately: management does not forecast volumes, which are the dominant swing factor. The only revised number this quarter was the expense line, trimmed $15M to ~$1.635B ex-license fees on cloud-migration optimization and lighter consulting. All other guidance was maintained. The absence of a volume or revenue guide is a feature, not a gap: it reflects the genuine unpredictability of trading activity that the CEO reiterated when pressed on the second-half outlook.

Implied second-half setup: The bar is high. H1 2025 delivered 14% earnings growth on record volumes; simply holding those levels would produce tougher year-over-year comps as the quarters roll forward, and the collateral-float tailwind narrows if rates fall. Expense discipline plus international and retail share gains are the offsets. Our base case is high-single-digit to low-double-digit full-year revenue growth, decelerating from the H1 pace as comps harden.

Guidance style: Consistent with CME's historical pattern of conservatism: guide only what is controllable (expenses, tax, capex), let volume fall where it may, and return the cash. This is the right way to run a volume-cyclical franchise, and it is one reason the stock earns a premium multiple. It also means catalysts are events (volatility spikes, product launches, rate moves) rather than guided inflections.

Analyst Q&A Highlights

The Second-Half Volume Outlook and Whether Records Can Persist

The opening question pressed management on the macro backdrop for the back half and which drivers, rates, commodities, or crypto, could sustain the first-half hedging surge. The CEO refused to forecast volumes but built an unusually explicit macro case for structural demand, anchored on record and rising sovereign debt across the US, Europe and the UK, plus unresolved geopolitical conflict.

Q: "Trading volume and hedging activities were very strong in the first half. CME had a record quarter again. But could you please talk about the macro backdrop for the second half? What are the key drivers that can sustain these strong hedging activities going into the second half? Is it going to be interest rates, commodities, crypto or something else?"
— Owen Lau, Oppenheimer

A: "It's really hard to predict volumes. We've always said that since the day we took this company public… But it doesn't negate the fact that we're sitting at record levels of debt, not only here in the United States. We're sitting at increasing levels of debt throughout Europe now… It is at levels that I think they're obviously unprecedented. And I think that people are going to need to manage and mitigate that risk."
— Terry Duffy, Chairman & CEO

Assessment: The refusal to forecast is itself a positive tell about management credibility, and the debt-issuance argument is the strongest structural underpinning of the volume thesis, because it is arithmetic rather than sentiment. The honest answer is that no one can predict whether the second half matches the first; the durable point is that the demand drivers are secular. This is the crux of why we rate the business highly but the stock only a Hold: the quality is real, the near-term volume is unknowable, and the multiple already assumes continuation.

Capital Deployment: Buybacks vs. the Variable Dividend

A question probed how management is prioritizing buybacks against the variable dividend given elevated cash balances, and whether inorganic opportunities are on the table. The response reaffirmed an unchanged, opportunistic framework and a deliberately choosy stance on M&A.

Q: "How are you thinking about capital deployment here, just given the level of cash balances… How are you thinking about prioritizing buybacks versus dividends, just given where the stock is? Any thoughts on inorganic growth opportunities in the current environment?"
— Chris Allen, Citi

A: "The way we're thinking about capital deployment has not changed… that's going to be an opportunistic program. So we still have our variable dividend structure and the ability to return cash through that valve, and we have the addition of the share repurchase that we can look to utilize if we see some disconnects in terms of trading versus performance… On the inorganic side… we just tend to be a bit more choosy in terms of when we pull that trigger."
— Lynne Fitzpatrick, CFO

Assessment: The message is continuity and discipline, which is what a high-quality compounder should offer. The buyback is a valuation-sensitive tool rather than a standing commitment, so investors should not model aggressive share shrinkage; the variable dividend remains the primary return valve. The choosiness on M&A is reassuring given the sector's poor deal history. Nothing here changes the thesis, but it reinforces that the total-return case rests on dividends plus modest EPS growth, not on financial engineering.

What Drove the Expense-Guide Reduction

Given the first-half records, an analyst asked what prompted management to lower rather than raise the expense guide, and whether it reflected timing or a structural change. The CFO attributed it to two specific items.

Q: "Given all the records that you guys have had in the first half of the year, curious what drove the expense guide takedown? So in terms of priorities… is this just timing in terms of spend? Or are there other changes in terms of expense outlook that you guys are making proactively?"
— Dan Fannon, Jefferies

A: "One was the refinement of our views on the spending on the Google migration. So we have been looking to optimize that spend… we're finding ways to minimize the incremental spend… The other area I would point out is we are coming in a bit lighter on the professional services thus far this year. So we're using a bit less of consulting help."
— Lynne Fitzpatrick, CFO

Assessment: Both drivers are constructive. The Google Cloud migration flipping from cost worry to savings source removes a real overhang, and lighter consulting spend signals genuine cost discipline rather than one-off timing. This is the mechanical engine behind the 71% margin, and it is durable enough to underwrite continued margin resilience even if volume growth decelerates. A clear incremental positive.

New Cash-Collateral Minimum and Its Contribution

An analyst asked how much the new soft minimum on cash collateral (effective April 1) and the associated non-cash surcharge contributed to results, and requested the average cash and non-cash balances. The CFO gave precise figures and, importantly, attributed most of the cash shift to volatility rather than to the policy itself.

Q: "CME introduced new cash collateral requirements in the quarter… To what extent did the new requirements contribute to results this quarter? And I believe there was an extra 10-basis-point charge for noncash collateral if certain minimums weren't maintained… can you just give us average cash and noncash collateral balances for the quarter?"
— Ken Worthington, JPMorgan

A: "The overall level of collateral… increased pretty significantly… our total collateral posted this quarter averaged $316 billion… about $133 billion was in cash, and $145 billion was in noncash collateral. So of the required amount, you had almost 48% posted in cash… the soft minimum was placed at 30%… as our customers get more accustomed to that soft minimum, we may see more of a rightsizing closer to that 30% target."
— Lynne Fitzpatrick, CFO

Assessment: The disclosure is the most model-relevant of the call. The willingness to flag that elevated cash was volatility-driven, and that balances may "rightsize" toward the 30% floor, is a candid guide-down on the float income tailwind. Combined with the rate-cut path, this frames the collateral spread as a normalizing rather than growing line into 2026. It is why we hold a conservative view on non-operating income despite the record operating quarter.

The RPC Trajectory Under International and Retail Cross-Currents

A question asked how to think about the rate per contract going forward given the tension between rising non-US (higher-RPC) activity and rising retail (lower-RPC) activity. The CFO declined to defend RPC as a target and redirected to the revenue base.

Q: "Just given the interplay of a rising non-U.S. rising retail opportunity set relative to the base business and the volume growth, how are you thinking about maybe the projection for RPC looking ahead?"
— Bill Katz, TD Cowen

A: "Those are two competing factors… as we continue to expand our international presence, that does tend to be nonmember activity, so that does tend to be at a bit higher RPC. On the flip side… the retail activity… may be participating in more of the smaller contracts… which does have a dampening effect on the average rate per contract. So for us, we are not focused on growing RPC. We're focused on growing that revenue base."
— Lynne Fitzpatrick, CFO

Assessment: The answer is analytically honest but is effectively a signal that RPC will stay under pressure and should not be a bull-case lever. For modeling, we treat blended RPC as roughly flat-to-slightly-down and let volume and mix drive fee revenue. Management is optimizing for total revenue, which is correct, but investors relying on volume records to imply proportional fee growth are set up for disappointment.

The Floor-Trader Litigation Overhang

An analyst raised the ongoing trial with former floor traders, where reported damages claims run into the billions, and asked how management is thinking about the case, reserving, and any effect on capital-return appetite. The CEO declined to engage on the pending matter beyond the prior public disclosure.

Q: "I had one on the trial that's currently ongoing with your former floor traders. The damages that the claims are seeking… seem to be rather large, $1 billion to $2 billion-plus… how are you thinking about this trial, your ability to win? And how should investors think about your reserving for any potential damages and whether that's had any impact on your capital return appetite?"
— Patrick Moley, Piper Sandler

A: "I don't mean to be short with you, but I'm just going to say, we cannot comment on pending litigation… We have said from the beginning that we have not accrued anything to date for this, and that's all we can say that we've already said publicly, but I'm not going to say anything further on the trial."
— Terry Duffy, Chairman & CEO

Assessment: The refusal to comment is appropriate but leaves a genuine, unquantified tail risk on the table. No accrual has been taken, so an adverse verdict at the upper end of the reported claims would be a real, if one-time, capital event. We do not size it in the base case, but it is a legitimate reason for a value-conscious investor to demand a margin of safety, and it reinforces the Hold rather than a more constructive rating at this price.

What They're NOT Saying

1. No defense of RPC: Management redirected every RPC question toward "total revenue." The unstated message is that blended RPC will keep drifting down, so the flattering read-across from 16% volume growth to fee growth does not hold, a nuance that is easy to miss from the headline.
2. The float-income cliff is under-narrated: Non-operating income benefited from ~$133B of cash collateral earning a spread, but management flagged only that balances may "rightsize" toward the 30% floor. What went unsaid is the compounding effect if Fed cuts arrive alongside lower cash balances, which would pressure a line that has quietly padded EPS.
3. FMX and rates competition went unmentioned: No question or comment addressed the emerging Treasury-futures challenger. Silence is not evidence of a threat, but management's confidence on the rates franchise was asserted rather than defended against the specific new entrant.
4. Litigation reserve strategy: Beyond "we have not accrued anything," there was no framing of the range of outcomes or timeline. With claims reportedly in the billions and zero reserve, the shape of the tail is left entirely to investor imagination.
5. No second-half or full-year revenue framework: Consistent with policy, but after a record H1 the absence of any guide on whether the run-rate is sustainable leaves the single most important variable, forward volume, completely open.

Market Reaction

• Pre-print setup: CME closed at $274.64 on July 22, entering the print up 18.3% year-to-date and up 39.1% over the trailing twelve months, near the top of a 52-week range of $193.71–$290.71. The stock had already priced in a strong quarter.
• Reaction session (July 23, before-open report): The stock gapped down slightly at the open ($274.22, −0.2%), traded a $273.31–$280.39 range, and closed at $276.48, up just 0.7% (+$1.84) on 2.7M shares (1.1x the 30-day average). The S&P 500 rose 0.8% the same day, so CME essentially matched the tape.

A 0.7% move on an all-time-record quarter that beat consensus is the single most instructive data point in the print. It says the buy-side had already positioned for strong volumes (the stock's 18% year-to-date run is the evidence), so the record numbers cleared a high bar rather than surprising to the upside. The muted reaction also reflects the two watch items the numbers surfaced: the continued RPC drift and the rate-cut risk to collateral float income, both of which cap the read-through from record volume to forward EPS.

For a name at a premium multiple, "great quarter, flat stock" is the classic signature of a fully-valued compounder. It is not a bearish signal, the business is performing, but it is precisely the setup in which paying up rarely pays off. We would rather own CME on a volatility-driven pullback or a multiple reset than into a record print that the market greeted with a shrug.

Street Perspective

Debate: Is the Volume Step-Up Structural or Cyclical?

Bull view: The drivers are secular, not episodic: record global debt issuance, the entrenchment of SOFR and CME's benchmarks, a structural retail adoption wave, and international share gains. Open interest up 7% year-over-year proves positions are being held, not just churned, so the base is stepping up durably.

Bear view: H1 2025 was flattered by tariff-shock volatility and a gold/crypto retail frenzy, both of which are cyclical. Comps get very hard, and a return to a low-volatility regime would expose how much of the record was event-driven.

Our take: Both are partly right, and the honest answer is that the durable component (debt, benchmarks, retail, international) is real but the incremental record was amplified by episodic volatility. We would underwrite the through-cycle base as meaningfully higher than two years ago, but not at the full H1 2025 run-rate. That gap is why we start at Hold rather than Outperform.

Debate: Does the Premium Multiple Still Have Room?

Bull view: A capital-light, wide-moat monopoly compounding earnings mid-teens with a 71% operating margin and a variable dividend deserves a scarcity premium; there is no comparable-quality asset, so the multiple is justified and can persist.

Bear view: At ~26x forward earnings after an 18% year-to-date run, the stock already capitalizes the quality. With RPC drifting, float income facing rate cuts, and comps hardening, the path to multiple expansion is narrow and the downside on any volume air-pocket is real.

Our take: The bears have the better of it on a 12-month horizon. This is a wonderful business, but at this multiple the total return is likely to approximate the dividend plus modest EPS growth, roughly market-like, which is the definition of a Hold. We would turn constructive on a de-rating.

Debate: How Real Are the New Growth Vectors (Crypto, Tokenization, FX Spot+)?

Bull view: Crypto is compounding 100%+, FX Spot+ is already pulling in new bank participants, and the Google-partnered tokenization effort positions CME to lead 24/7 settlement, giving the story genuine new legs beyond the mature core.

Bear view: Each is small, early, and faces well-funded competition; crypto is a rounding error on volume, perpetuals are legally blocked in the US, and tokenization is a 2026-and-beyond promise. None move the near-term numbers.

Our take: We credit these as option value, not base-case revenue. They matter for the long-run narrative and for insulating CME against disruption, but they will not drive the next twelve months of earnings. Correctly valued as free upside on top of the core, which is another reason the core valuation is what decides the rating.

Model Update Needed

Valuation impact: Higher near-term operating earnings (margin + volume) are largely offset by a more conservative non-operating line and a full starting multiple. Net, we see fair value roughly in line with the current ~$276 price on a 12-month view, consistent with a Hold. A move into the low-$250s or a genuine acceleration in the through-cycle volume base would shift us to Outperform.

Thesis Scorecard Post-Earnings

This is our initiation, so the scorecard below establishes the standing thesis against which we will grade every subsequent quarter.

Overall: Thesis established. This is a top-tier, wide-moat, capital-light franchise executing at a very high level, and all four bull pillars are confirmed in the print. The constraint is entirely on the stock, not the business: a full multiple, a hardening comp base, and a rate-sensitive non-operating line together cap the 12-month risk/reward.

Action: Initiate at Hold. Own the quality on a pullback or a de-rating; at ~$276 into record numbers the market greeted with a shrug, patience is the better position. We would upgrade on a move toward the low-$250s or on evidence that the through-cycle volume base has genuinely stepped up rather than spiked.